Liraglutide reduces postprandial hyperlipidaemia by increasing apoB48 catabolism and by reducing apoB48 production

B Vergès (1, 2) , Laurence Duvillard (2, 1) , Benjamin Bouillet (2, 1) , Sabine Baillot-Rudoni (2) , P. Buffier (2) , E. Crevisy (2) , J-M Petit (2, 1)

1 LNC - Lipides - Nutrition - Cancer [Dijon - U1231]
2 CHU Dijon - Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand

Mots clés: Postprandial hyperlipidemia; Diabetic dyslipidemia; GLP1 agonist; liraglutide; apoB48

Domaines: Endocrinologie et métabolisme

B Vergès, Laurence Duvillard, Benjamin Bouillet, Sabine Baillot-Rudoni, P. Buffier, et al.. Liraglutide reduces postprandial hyperlipidaemia by increasing apoB48 catabolism and by reducing apoB48 production. The 52nd EASD Annual Meeting, Sep 2016, Munich, Germany. pp.S310/ 653. ⟨hal-01578949⟩